P&G Hygiene and Health Care Limited has announced a significant executive role transition, informing stock exchanges about changes in its senior management structure. The company has communicated this development to both BSE Limited and National Stock Exchange of India Limited under SEBI regulatory requirements.

Executive Role Transition Details

The company has announced that Mr. Ghanashyam Hegde will be transitioning from his current role to a broader regional position within the Procter & Gamble organization. This change represents an expansion of responsibilities across multiple markets.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions, including changes in key managerial personnel.

The communication was formally addressed to both major Indian stock exchanges where the company's shares are listed. The company trades under scrip code 500459 on BSE Limited and symbol PGHH on the National Stock Exchange of India Limited.

Company Information

Procter & Gamble Hygiene and Health Care Limited operates from its registered office at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai. The company, incorporated in 1964, holds CIN L24239MH1964PLC012971 and maintains its corporate website at in.pg.com.

The official communication was signed by Flavia Machado as the authorized signatory, ensuring proper corporate governance protocols were followed in making this announcement to the investment community and regulatory authorities.

P&G Hygiene and Health Care]( https://scanx.trade/company/procter-gamble-hygiene-health-care-ltd ) delivered a strong financial performance in Q3FY26, demonstrating resilience in its core health and hygiene products business. The company's net profit grew 12.2% year-on-year to ₹301.46 crore for the quarter ended December 31, 2025, compared to ₹268.59 crore in the corresponding quarter of the previous year.

Financial Performance Overview

The company's quarterly results showed mixed revenue performance with marginal growth in overall operations. Revenue from operations increased by 1.1% to ₹1,261.90 crore in Q3FY26 from ₹1,247.63 crore in Q3FY25. However, the nine-month performance painted a more robust picture with significant profit growth.

Nine-Month Performance Highlights

The company's nine-month performance for FY26 demonstrated strong operational efficiency and profitability improvements. Net profit for the nine months ended December 31, 2025, surged 25.3% to ₹703.37 crore compared to ₹561.55 crore in the corresponding period last year.

Dividend Declaration and Corporate Actions

The Board of Directors approved a substantial interim dividend for FY26, reflecting the company's strong cash generation and commitment to shareholder returns. The interim dividend of ₹195 per equity share includes a regular dividend component and a one-time special dividend of ₹25 per share.

Operational and Cost Management

The company demonstrated effective cost management across various expense categories. Employee benefits expense decreased to ₹61.67 crore in Q3FY26 from ₹66.17 crore in Q3FY25. Advertising and sales promotion expenses were optimized at ₹145.48 crore compared to ₹158.34 crore in the previous year quarter, indicating strategic marketing spend management.

Business Segments and Future Outlook

P&G Hygiene and Health Care operates in two primary segments: Health Care Products comprising ointments, creams, cough drops and tablets, and Hygiene Products including feminine hygiene products and other skin care hygiene items. The company has aggregated these segments into a single reportable segment focused on manufacturing, trading and marketing of health and hygiene products.

The company continues to monitor regulatory changes, particularly the implementation of the new Labour Codes effective from November 21, 2025, though management expects minimal financial impact given the current salary structure's alignment with new requirements.